Early tumor shrinkage served as a prognostic factor for patients with stage III non-small cell lung cancer treated with concurrent chemoradiotherapy

BACKGROUND: Lung cancer is the most common cause of cancer death. About 80% of patients are diagnosed at stage III in the non-small cell lung cancer (NSCLC). It is extremely important to understand the progression of this disease which has low survival times despite the advancing treatment modalitie...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Min, Ye, Qingqing, Wang, Xuan, Wang, Men, Hu, Yan, Yang, Yonghua, Yang, Jiyuan, Cai, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5959434/
https://www.ncbi.nlm.nih.gov/pubmed/29742701
http://dx.doi.org/10.1097/MD.0000000000010632

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5959434/
https://www.ncbi.nlm.nih.gov/pubmed/29742701
http://dx.doi.org/10.1097/MD.0000000000010632

Ejemplares similares